D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
IDYA holding history
IDEAYA Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IDYA overviewAll 13F holders of IDYAFull Q2 2026 holdings
- Shares (Q2 2026)
- 20,763
- Value
- $773.8K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 20,763 | $773.8K | <0.1% | +20,763 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −98,153−100.0% | Sold out | Holders |
| Q2 2025 | 98,153 | $2.06M | <0.1% | −210,403−68.2% | Reduced | Holders |
| Q1 2025 | 308,556 | $5.05M | <0.1% | +127,880+70.8% | Added | Holders |
| Q4 2024 | 180,676 | $4.64M | <0.1% | −387,055−68.2% | Reduced | Holders |
| Q3 2024 | 567,731 | $18.0M | <0.1% | −316,807−35.8% | Reduced | Holders |
| Q2 2024 | 884,538 | $31.1M | <0.1% | +226,514+34.4% | Added | Holders |
| Q1 2024 | 658,024 | $28.9M | <0.1% | +128,518+24.3% | Added | Holders |
| Q4 2023 | 529,506 | $18.8M | <0.1% | +93,148+21.3% | Added | Holders |
| Q3 2023 | 436,358 | $11.8M | <0.1% | +223,143+104.7% | Added | Holders |
| Q2 2023 | 213,215 | $5.01M | <0.1% | +116,156+119.7% | Added | Holders |
| Q1 2023 | 97,059 | $1.33M | <0.1% | +76,118+363.5% | Added | Holders |
| Q4 2022 | 20,941 | $380.5K | <0.1% | +20,941 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −24,590−100.0% | Sold out | Holders |
| Q1 2022 | 24,590 | $275.0K | <0.1% | −22,927−48.3% | Reduced | Holders |
| Q4 2021 | 47,517 | $1.12M | <0.1% | +27,710+139.9% | Added | Holders |
| Q3 2021 | 19,807 | $505.0K | <0.1% | +19,807 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −19,293−100.0% | Sold out | Holders |
| Q1 2021 | 19,293 | $453.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.